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Summary
Tibial muscular dystrophy (TMD) is a rare autosomal
dominant distal myopathy with late adult onset. The
phenotype is relatively mild: muscle weakness manifests
in the patient’s early 40s and remains confined to the
tibial anterior muscles. Histopathological changes in
muscle are compatible with muscular dystrophy, with
the exception that rimmed vacuoles are a rather common
finding. We performed a genomewide scan, with 279
highly polymorphic Cooperative Human Linkage Center
microsatellite markers, on 11 affected individuals of one
Finnish TMD family. The only evidence for linkage
emerged from markers in a 43-cM region on chromo-
some 2q. In further linkage analyses, which included
three other Finnish TMD families and which used a
denser set of markers, a maximum two-point LOD score
of 10.14 (recombination fraction of .05) was obtained
with marker D2S364. Multipoint likelihood calcula-
tions, combined with the haplotype and recombination
analyses, restricted the TMD locus to an ∼1-cM critical
chromosomal region without any evidence of hetero-
geneity. Since all the affecteds share one core haplotype,
the dominance of one ancestor mutation is obvious in
the Finnish TMD families. The disease locus that was
found represents a novel muscular dystrophy locus, pro-
viding evidence for the involvement of one additional
gene in the distal myopathy group of muscle disorders.
Introduction
Distal myopathies represent a group of relatively rare
inherited muscle diseases with unknown etiology and
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without any identified gene defect, to date. One repre-
sentative of this group is tibial muscular dystrophy
(TMD; MIM 600334), in which the muscle weakness
manifests in the patient’s early 40s and, to a large extent,
remains confined to the tibial anterior muscles, leading
to a mild foot drop 10–15 years after the onset of muscle
weakness. The overall disability is mild, and patients
remain ambulatory throughout their lives (Udd et al.
1991b). The morphological findings are compatible with
muscular dystrophy, as anterior tibial muscles arewasted
and replaced by adipose and connective tissue (Udd et
al. 1992). Rimmed vacuoles are frequently detected in
the muscle biopsy (Udd et al. 1993). TMDwas originally
described in a large Finnish pedigree from an internal
isolate (Udd et al. 1991a). Interestingly, in this pedigree
with a high degree of remote consanguinity, six family
members had a more severe, limb-girdle muscular dys-
trophy (LGMD). Their clinical features included a pro-
gress rate resembling childhood/juvenile-onset LGMD
(Udd et al. 1991a).
Additional families with only the classic TMD phe-
notype have been found subsequently in Finland (Udd
et al. 1993; Partanen et al. 1994). The estimated disease
prevalence is x5/100,000 (B. Udd, unpublished data).
Thus far, TMD has been detected only in Finland, sug-
gesting that it is a new member of the Finnish disease
heritage, enrichment of which is due to isolation (Norio
1981; Peltonen et al. 1995).
In some distal myopathies, the locus assignment has
been established. Miyoshi myopathy, in which the plan-
tar flexors are initially affected, has been localized to
2p12-14 (Bejaoui et al. 1995). For Nonaka myopathy
(in which the anterior tibialis muscles are initially af-
fected) and for hereditary inclusion body myopathy, the
loci have been assigned to chromosome 9p1-q1 (Argov
et al. 1997; Ikeuchi et al. 1997), and, finally, one au-
tosomal dominant form of distal myopathy has been
mapped to chromosome 14 (Laing et al. 1995). The
LGMDs are also a genetically heterogeneous group of
muscle diseases. Two dominant forms and seven re-
cessive forms have been mapped, thus far, and five de-
fective genes have been identified in the recessive forms
(table 1).
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Table 1
LGMD Loci and Identified Genes
LGMD
Locus Inheritancea
Chromosomal
Localization Geneb Symbol
1A AD 5q31-33 ) )
1B AD 1q11-21 ) )
2A AR 15q15 Calpain3 CAPN3
2B AR 2p12-13 ) )
2C AR 13q12 g-SG SGCG
2D AR 17q12-21 a-SG SGCA
2E AR 4q12 b-SG SGCB
2F AR 5q33 d-SG SGCD
2G AR 17q11-12 ) )
NOTE.—Data from the studies by Beckmann et al. (1991); Ben
Othmane et al. (1992); Azibi et al. (1993); Bashir et al. (1994);
Roberds et al. (1994); Yamaoka et al. (1994); Lim et al. (1995);
Noguchi et al. (1995); Richard et al. (1995); Nigro et al. (1996);
Passos-Bueno et al. (1996); Moreira et al. (1997); and van der
Kooi et al. (1997).
a AD  autosomal dominant; AR  autosomal recessive.
b SG  sarcoglycan.
Figure 1 Order of markers and approximate intermarker dis-
tances on chromosome 2q31.
In this article, we present results from a genomewide
scan of one large Finnish TMD family and assign the
TMD locus to a restricted region on chromosome 2q31
(fig. 1). We also provide initial evidence that, in one
inbred family, a more severe, LGMD-type disease is as-
sociated with homozygosity of the same disease
haplotype.
Subjects, Material, and Methods
Methods used for clinical examination, as well as the
diagnostic criteria, have been described elsewhere (Udd
et al. 1993). The features of the TMD and LGMD phe-
notypes are summarized in table 2. The genome scan
was performed for 11 affected and 6 healthy individuals
from family A (fig. 2). Family B (fig. 3) represents a part
of the large inbred pedigree in which TMD was origi-
nally described (Udd et al. 1991a). The other two fam-
ilies (C and D, not shown), with four affected individuals
in each, are not known to be related to either family A
or family B.
DNA for genotyping was extracted from whole-blood
samples from consenting individuals (as described in the
study by Vandenplas et al. [1984], with modifications
for the use of Phase Lock Gel). The study protocol was
accepted by the Ethical Board of the University of
Helsinki.
The genome scan was performed, by use of the ABI
prism system and Genotyper 2.0 software (Perkin-Elmer,
Applied Biosystems), with 279 highly polymorphic fluo-
rescent microsatellite markers of Cooperative Human
Linkage Center set 6A, which is an improvement of set
5 (Dubovsky et al. 1995). Additional loci were typed by
use of g-[32P]ATP–labeled markers from the Ge´ne´thon
map (update March 1996). The order of the markers
has been obtained mostly from the physical YAC contig
map of chromosome 2 (Chumakov et al. 1995), sup-
plemented by the Ge´ne´thon map. The approximate ge-
netic distances are according to the Ge´ne´thon map (fig.
1). PCR reactions, electrophoresis, and genotyping were
performed with minor modifications to procedures de-
scribed elsewhere (Aaltonen et al. 1993).
Two-point LOD-score calculations were performed by
use of the MLINK option of the LINKAGE package of
programs (Lathrop and Lalouel 1984; Cottingham et al.
1993; Scha¨ffer et al. 1994). The SLINK option was util-
ized to estimate the informativeness of the family ma-
terial used in the linkage analyses (Ott 1989; Weeks et
al. 1990). The VITESSE algorithm was used for multi-
point likelihood calculations (O’Connell and Weeks
1995), for which family B had to be subdivided, owing
to multiple founders in the family. Autosomal dominant
inheritance with complete penetrance was assumed, and
the gene frequency was set to .0001; young subjects (!35
years of age) were scored as unknown in the linkage
analyses, owing to the late onset of the disease. The
patients with the LGMD phenotype were considered as
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Table 2
Comparison of the TMD and LGMD Phenotypes
TMD Phenotype LGMD Phenotype
Clinical findings Weakness in tibial anterior muscles
(ankle dorsiflexion affected);
patients unable to walk on their
heels
Weakness in all proximal muscles;
distal muscles less severely af-
fected; facial muscles unaffected
Age at onset 4th–8th decade 1st–3d decade
Progression Slow progress in anterior compart-
ment muscles; mild proximal leg-
muscle weakness in a minority of
patients
Loss of ambulation between 3d
and 6th decade
Findings from
muscle biopsya
Varies from mild myopathic changes
to severe muscular dystrophy;
rimmed vacuoles may be present
Severe muscular dystrophy in prox-
imal muscles; mild changes in
distal muscles
Findings from
computed tomography/
magnetic resonance
imaging
Fatty degeneration of anterior tibial
muscles; patchy lesions in asympto-
matic muscles
Fatty replacement and atrophy in
proximal muscles
a Histopathological changes are variable, depending on the stage of the disease process. All patients in the
LGMD group underwent muscle biopsy at a relatively late stage of the disease.
affected in the linkage analyses (fig. 3). The allele fre-
quencies of the markers were obtained from the healthy
chromosomes ( ). Male and female recombinationn  20
fractions (v) were assumed to be equal.
Results
Family A was utilized in the initial genomewide scan
for the TMD locus, since, in the simulation analysis, this
family alone was predicted to provide significant evi-
dence for linkage, with an expected average LOD score
of 4.34. The primary genomewide scan, using 279mark-
ers, revealed only one interesting area, with a maximum
two-point LOD score 13 in the pairwise analyses. Pos-
itive LOD scores were observed with markers D2S1776,
D2S1391, D2S1384, and D2S1649, which span a 43-
cM region (fig. 1). The maximum two-point LOD score
of 6.31 was obtained with marker D2S364 ( ).v  .00
When three additional TMD families were analyzedwith
the markers for this region, significant LOD scores of
3.12 ( ) and 3.47 ( ) were obtained in fam-v  .00 v  .00
ily B, with markers D2S364 and D2S385, respectively.
Families C and D did not provide significant evidence
for linkage to any of the markers in the pairwise anal-
yses. However, when information from all four families
was combined, the evidence for linkage increased. The
maximum two-point LOD score of 10.14 ( ) wasv  .05
obtained with marker D2S364, in the pooled data set,
and no evidence for genetic heterogeneity emerged from
the statistical analyses.
Multipoint likelihood calculations assigned the TMD
locus to be within close proximity of marker D2S324,
which gave a maximum multipoint LOD score of 10.05
( ) (fig. 4). Haplotype analysis was performed onv  .00
the basis of the haplotypes formed when a minimum
number of recombination events was allowed (figs. 2
and 3). In families A, B, and D the analysis revealed a
common core haplotype, since all affected individuals
shared identical alleles on markers D2S138, D2S148,
D2S2173, D2S300, D2S385, D2S324, D2S2310, and
D2S364. Family C shared this haplotype identity with
markers D2S138, D2S148, D2S2173, D2S300, D2S385,
and D2S324, suggesting one restricted core haplotype
in all the families analyzed. Furthermore, one healthy
individual in family B shared the chromosomal haplo-
type of TMD, up to marker D2S148. This set the prox-
imal boundary for the TMD region (fig. 3). The core
haplotype and the recombinations thus restrict the crit-
ical area to an ∼1-cM region between markers D2S148
and D2S2310.
Six patients in family B had a more severe, LGMD-
type of disease. Three individuals, with childhood onset
of LGMD and loss of ambulation already in the 3d dec-
ade, were homozygous for the disease allele (fig. 3). Al-
though the other three individuals had LGMD, onset of
the disease had been in adolescence, and they had lost
ambulation in the 6th decade. They shared only one
TMD chromosome, like that found in the TMD-affected
members of the family (data not shown).
Discussion
Our findings provide evidence for a novel muscular
dystrophy locus, via the assignment of the TMD locus
to chromosome 2q31, between markers D2S148 and
D2S2310. The number of disease chromosomes in our
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Figure 2 Pedigree of family A, showing chromosome 2q haplotypes. Individuals marked with an asterisk (*) were included in the genome
scan. The haplotype cosegregating with the disease is boxed.
Figure 3 Pedigree of family B, showing chromosome 2q haplotypes. The common core haplotype shared with family A is boxed. Hatched
symbols indicate individuals with the more severe, LGMD phenotype. The dotted symbol indicates an individual with an unknown phenotype.
In marker D2S2173, allele 4 probably represents an old mutated version of allele 3. The major alleles of the markers are as follows: D2S2188
allele 7; D2S138 allele 6; D2S148 allele 9; D2S2173 allele 3; D2S300 allele 4; D2S385 allele 6; D2S324 alleles 1 and 5; D2S2310 alleles 3 and
8; D2S364 alleles 2 and 13; and D2S1391 alleles 5, 7, and 8. Each of these alleles was present in x25% of healthy chromosomes.
study material was too low to provide statistical evidence
for linkage disequilibrium in this dominant disorder.
However, the haplotype analyses suggested that all af-
fected individuals share one common core haplotype
and, thus, predict one major ancestral TMD mutation
in the Finnish population. Analysis of the core haplo-
type, defined by use of a relatively dense set of markers,
actually provided information on ancient recombination
events and restricted the critical chromosomal region.
In the highly inbred family B, the occurrence of the
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Figure 4 Multipoint linkage analysis of the TMD locus, against a fixed set of markers. The markers used are shown below the horizontal
axis. The intermarker distances and the order between the markers indicated as a cluster are not well established. The order indicated here is
most compatible with the haplotypes analyzed. Distances are indicated in centimorgans (cM).
more severe, LGMD phenotype together with the milder
TMD phenotype is not a unique event in families with
muscular dystrophy. Two families have been described
with a distal myopathy and LGMD phenotypes, which
segregate in an autosomal recessive fashion. Linkage
analyses of these families revealed a chromosome 2p
locus that harbors both the autosomal recessive LGMD
locus (LGMD2B) and the Miyoshi myopathy locus. It
was suggested that the different disease phenotypes re-
sulted from the same disease-causing mutation but that
the phenotype was additionally influenced by other ge-
netic or environmental factors (Illarioshkin et al. 1996;
Weiler et al. 1996). In family B, the two phenotypes also
are linked to the same locus, and the most severe LGMD
phenotype seems to be associated with homozygosity of
the disease allele. This could be caused by inbreeding,
and the LGMDphenotype could result from the presence
of another recessive muscular dystrophy locus cosegre-
gating in the family. Alternatively, a secondary gene may
directly influence disease severity, as was described re-
cently for a mouse model of cystic fibrosis (Rozmahel
et al. 1996).
Our findings provide the basis for further attempts to
identify the TMD gene. The relatively well restricted
critical chromosomal region on 2q31 contains good can-
didate genes, including a gene for titin, a giant structural
protein of muscle (Labeit and Kolmerer 1995). In ad-
dition, two genes encoding collagen chains (COL3A1
and COL5A2), expressed in the endo- and perimysium
of the muscle, were initially assigned to 2q32 (Collins
et al. 1996). The titin is claimed to contribute to the
myofibrillar assembly and elasticity of striated muscle
(Labeit and Kolmerer 1995). Furthermore, titin is com-
posed of slightly different domains in different types of
skeletal and heart muscle, owing to alternative splicing
(Labeit and Kolmerer 1995; Kolmerer et al. 1996; So-
rimachi et al. 1997). The tissue-specific expression of the
differentially spliced titin transcripts could explain the
selective muscular affection pattern of TMD. Conse-
quently, the titin gene could be an excellent candidate
gene for TMD.
Our further studies are focused on the structural anal-
yses of this gigantic (100-kb cDNA) gene, as well as on
other candidate genes in the critical chromosomal re-
gion. Also, novel positional candidate genes will be iden-
tified via the construction of the complete transcript
map. These efforts eventually should result in the char-
acterization of the gene defect causing TMD.
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